期刊
TICKS AND TICK-BORNE DISEASES
卷 7, 期 1, 页码 193-198出版社
ELSEVIER GMBH
DOI: 10.1016/j.ttbdis.2015.10.005
关键词
Tickborne disease; Laboratory; Diagnostic testing; Babesiosis; Anaplasmosis
资金
- CDC Cooperative Agreements [5U01C1000307, 5U01C100031005, 5U01C1000313, 5U01C100031004]
- NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000307] Funding Source: NIH RePORTER
Large commercial laboratories in the United States were surveyed regarding the number of specimens tested for eight tickborne diseases in 2008. Seven large commercial laboratories reported testing a total of 2,927,881 specimens nationally (including Lyme disease). Of these, 495,585 specimens (17%) were tested for tickborne diseases other than Lyme disease. In addition to large commercial laboratories, another 1051 smaller commercial, hospital, and government laboratories in four states (CT, MD, MN, and NY) were surveyed regarding tickborne disease testing frequency, practices, and results. Ninety-two of these reported testing a total of 10,091 specimens for four tickborne diseases other than Lyme disease. We estimate the cost of laboratory diagnostic testing for non-Lyme disease tickborne diseases in 2008 to be $9.6 million. These data provide a baseline to evaluate trends in tickborne disease test utilization and insight into the burden of these diseases. (C) 2015 Elsevier GmbH. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据